Clik here to view.
十年磨一剑，Biosafe Defenses LLC宣布新突破性消毒剂
新墨西哥州阿尔伯克基 (美国商业资讯)–全球领先的家用、医院用和工业用全新光敏消毒剂、杀菌剂和抗微生物剂生产商Biosafe Defenses LLC（前身为Biosafe Technologies LLC）刚刚宣布在美国斩获第九项关键专利，名为“阳离子共轭聚合物与使用方法”(Conjugated Polyelectrolytes and Methods of Using the...
View ArticleClik here to view.
Internationally Renowned Virologist Christian Bréchot Appointed President of...
MELBOURNE, Australia The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 24 countries, dedicated to...
View ArticleClik here to view.
Clik here to view.
22nd Century与英美烟草之间的限制性许可协议终止
纽约克拉伦斯 (美国商业资讯)–专注于减少烟草中有害成份的植物生物科技公司22nd Century Group, Inc. (NYSE American: XXII)欣然宣布，本公司与英美烟草（投资）有限公司(British American Tobacco (Investments) Limited, “BAT”)在2013年签订的研究许可证和商业选择协议现已到期。BAT不再享有22nd...
View ArticleClik here to view.
Takeda to Feature ALUNBRIG™ (brigatinib) Data from Pivotal Phase 2 ALTA Trial...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will present four company-sponsored abstracts, including one oral presentation,...
View ArticleClik here to view.
Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based...
OSAKA, Japan & SAN DIEGO & STOCKHOLM Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), Karolinska Institutet (“KI”) and The Structural Genomics Consortium (“SGC”) today announced...
View ArticleClik here to view.
武田在第18届世界肺癌大会上呈报通过枢纽性2期ALTA 临床试验获得的ALUNBRIG™ (brigatinib)数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，该公司将在国际肺癌研究协会(IASLC)的第18届世界肺癌大会(WCLC)上呈报4篇由公司资助的研究摘要，其中包括一场口头报告，本届大会将于10月15-18日在日本横滨召开。本届会议上的报告将突出强调武田在开发ALUNBRIGTM...
View ArticleClik here to view.
武田薬品、第18回世界肺がん学会議でピボタル第2相ALTA試験から得たALUNBRIG™（ブリガチニブ）のデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Herbalife Nutrition Survey Reveals APAC Consumers Concerned About...
HONG KONG Premier global nutrition company, Herbalife (NYSE: HLF) today released findings from its Asia Pacific Healthy Aging Survey, of 6,000 respondents aged 40 and above from Australia, Hong...
View ArticleClik here to view.
CDISC Releases Therapeutic Area User Guide to Accelerate Development of...
AUSTIN, Texas The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the release of a new Therapeutic Area Standard for Vaccines in the form of a User Guide for data...
View ArticleClik here to view.
Accenture Helps Dai-ichi Life Expand Its Digital Health Promotion Services
TOKYO Accenture (NYSE:ACN) has helped Dai-ichi Life Insurance Company, Limited (“Dai-ichi Life”) enhance its Kenko Dai-ichi (Health First) app, which promotes healthy lifestyle choices and enables...
View ArticleClik here to view.
ウォルターズ・クルワー、UpToDateの誕生25周年にあたり 25番目の専門領域として麻酔学を追加
WALTHAM, Mass. *本リリースは、2017年10月3日（現地時間）に米国で発表したプレスリリースを日本語に翻訳したものです。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。： http://www.businesswire.com/news/home/20171005005698/ja/...
View ArticleClik here to view.
SAISON INFORMATION SYSTEMS: Data Integration Streamlines Japanese City’s...
TOKYO Saison Information Systems Co., Ltd. (JASDAQ:9640) (Headquarters: Tokyo, Japan; President: Kazuhiro Uchida; herein, “Saison Information Systems”) is the maker of HULFT, middleware for managed...
View ArticleClik here to view.
22ndセンチュリーのスペクトラム研究用紙巻きたばこを使用した第3相研究で、超低ニコチンへの即時の低減がタバコの有害性を最も減らし得ることを証明
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減に傾注する植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE American:...
View ArticleClik here to view.
SAISON INFORMATION SYSTEMS：数据集成助力日本城市的医疗保健服务
东京 (美国商业资讯)–Saison Information Systems Co., Ltd.(JASDAQ:9640)（总部：日本东京；总裁：Kazuhiro Uchida；下称“Saison Information...
View ArticleClik here to view.
Innovus Pharmaceuticals Expands Its International Proprietary Product Patent...
SAN DIEGO Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company...
View ArticleClik here to view.
Cogstate Announces First U.S. Deployment of the Cognigram™ System at the...
BOSTON The cognitive science company, Cogstate today announced the commercial deployment of its Cognigram™ digital cognitive assessment system at the University of Notre Dame. This placement...
View ArticleClik here to view.
Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic®...
OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic® (naldemedine) 0.2 mg tablets are now available throughout the United...
View ArticleClik here to view.
Anika Announces Regulatory Approval for MONOVISC® in Australia for the...
BEDFORD, Mass. Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology,...
View ArticleClik here to view.
Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery...
OSAKA, Japan & CHARLOTTESVILLE, Va. Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to...
View Article